Abstract: The present invention relates to a composition comprising Bacterial Ghosts, optionally an active agent, and a pharmaceutically acceptable carrier and/or excipient for use in the treatment of cancer.
Type:
Grant
Filed:
January 20, 2017
Date of Patent:
September 15, 2020
Assignee:
BIRD-C GMBH
Inventors:
Werner Lubitz, Pavol Kudela, Marek Sramko
Abstract: The invention relates to a fed-batch process for the production of bacterial ghosts based on the decoupling of the lytic gene expression and actual lysis of bacterial cells.
Type:
Grant
Filed:
February 20, 2015
Date of Patent:
January 7, 2020
Assignee:
Bird-C GmbH & Co. KG
Inventors:
Werner Lubitz, Christian Herwig, Timo Langemann, Patrick Sagmeister
Abstract: The present invention relates to a composition comprising Bacterial Ghosts, optionally an active agent, and a pharmaceutically acceptable carrier and/or excipient for use in the treatment of cancer.
Type:
Application
Filed:
January 20, 2017
Publication date:
January 31, 2019
Applicant:
BIRD-C GMBH
Inventors:
Werner Lubitz, Pavol Kudela, Marek Sranko
Abstract: The invention relates to a fed-batch process for the production of bacterial ghosts based on the decoupling of the lytic gene expression and actual lysis of bacterial cells.
Type:
Application
Filed:
February 20, 2015
Publication date:
July 19, 2018
Applicant:
BIRD-C GMBH & CO KG
Inventors:
Werner LUBITZ, Christian HERWIG, Timo LANGEMANN, Patrick SAGMEISTER